megalabs chile

What megalabs chile does

Megalabs Chile S.A. is a Santiago-based pharmaceutical manufacturer and distributor operating as a wholly-owned subsidiary of Megalabs Global, a multinational pharmaceutical group with presence in 18 countries. The company manufactures and distributes prescription pharmaceuticals, over-the-counter products, medical devices, specialized nutrition, and skincare lines across eleven or more therapeutic areas including cardiovascular, gastroenterology, dermatology, neuropsychiatry, ophthalmology, oncology, bone metabolism, pediatrics, and urology. Its portfolio is organized into five operating units: Megalabs (core pharmaceuticals), Royal Pharma (dermatology and neuropsychiatry, including products such as Inflader, Folipil, Qurax XR, Procelar, and Prozone), Medical Device (ophthalmic products under the POEN brand), Victus (general and specialized medical nutrition for diabetic, hepatic, and renal conditions), and Pharma Investi. Notable proprietary or differentiated formulations include the VINTIX Saccharomyces boulardii probiotic antidiarrheal, INFLADER isotretinoin soft-capsule acne treatment, Procelar biomimetic-peptide eyelash growth gel, and Prozone Gel sunscreen with a patented melanin-in-microsponge antioxidant system.

The company operates a B2B, sales-led go-to-market focused on healthcare professionals and institutions. Distribution is split between a pharmacy channel (chains and independents) and a direct enterprise sales channel to hospitals and healthcare institutions, supported by professional marketing through the corporate website and direct sales interactions rather than direct-to-consumer advertising. Revenue is generated through one-time product sales of prescription medications, OTC products, hardware medical devices, nutritional supplements, and skincare items; pricing is not publicly disclosed and is managed via sales inquiry. The company emphasizes bioequivalent product certification, pharmacovigilance, and tecnovigilancia as functional differentiators and operates from its headquarters at Avenida Andrés Bello 1495, Providencia, Santiago, with a headcount of 51-100 employees.

Megalabs Chile was previously known as Pharma Investi Chile and has since been rebranded and integrated into the Megalabs global network, consolidating the legacy Pharma Investi identity with newer dermatology, neuropsychiatry, nutrition, and medical device units. The business model is consistent with a traditional mid-sized branded-generic and specialty pharma distributor serving the Chilean market, with no evidence of AI/ML capabilities, software products, or external funding activity.

Name

megalabs chile

Legal name

Megalabs Chile S.A.

Website

https://megalabschile.cl

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Megalabs Chile is a Santiago-based pharmaceutical manufacturer and distributor, operating as a subsidiary of Megalabs Global, selling prescription drugs, OTC products, medical devices, specialized nutrition, and skincare across 11+ therapeutic areas to pharmacies, hospitals, and healthcare institutions throughout Chile.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Pharmaceutical manufacturing
• Generic medications
• Bioequivalent drugs
• Dermatology treatments
• Medical nutrition

Headquarters

HQ city

Santiago

HQ country

Chile

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical product sales: Sale of prescription and over-the-counter pharmaceutical products across multiple therapeutic areas including cardiovascular, gastroenterology, dermatology, neuropsychiatry, ophthalmology, oncology, and pediatrics. Revenue generated through pharmacy and healthcare provider distribution.
2. Medical device products: Sale of medical devices including ophthalmic products (POEN Colirios) and other medical equipment through specialized distribution channels.
3. Specialized nutrition (Victus): Sale of specialized nutritional products including Enterex diabetic formulas, hepatic formulas, and protein supplements for medical use.
4. Skincare products: Sale of skincare product lines including C-Vital, LIFT THERAPY, and VITAL AGE through pharmacy and retail channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Megalabs Chile manufactures and distributes prescription and over-the-counter pharmaceutical products across more than 11 therapeutic areas (cardiovascular, gastroenterology, dermatology, neuropsychiatry, ophthalmology, oncology, pediatrics, urology, gynecology, bone metabolism, broncopulmonary/ENT). The company also markets medical devices (ophthalmic products), specialized medical nutrition (Victus line), and skincare product lines (C-Vital, LIFT THERAPY, VITAL AGE), supplying these to pharmacies, hospitals, and healthcare providers in Chile.

Product overview

Megalabs Chile is a pharmaceutical company organized into four main business areas: Megalabs (core pharmaceutical products), Royal Pharma (specializing in dermatology and neuropsychiatry), Medical Device (ophthalmic products under POEN brand), and Victus (general and specialized nutrition). The company operates across 18 countries with manufacturing facilities of regional reference. Their product portfolio includes prescription medications across therapeutic areas (respiratory, cardiovascular, gastroenterology, gynecology, neuropsychiatry, ophthalmology, oncology, bone metabolism, pediatrics, urology), over-the-counter products, bioequivalent pharmaceuticals, and skincare lines including C-VITAL (antioxidant hydrating products), LIFT THERAPY (firming anti-aging treatments), and VITAL AGE (anti-wrinkle creams). The company emphasizes bioequivalence, pharmacovigilance, and technovigilance programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Vintix

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/megalabs-chile

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about megalabs chile